{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:29:27Z","timestamp":1791779367077,"version":"4.3.4"},"reference-count":11,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T00:00:00Z","timestamp":1098316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Malignant cells characteristically possess high levels of plasminogen activator, which induce local fibrinolysis. The DR\u201070 immunoassay is a newly developed test, which quantifies fibrin degradation products in serum by a proprietary antibody.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate the DR\u201070 immunoassay as a detection assay for the presence of gastrointestinal cancers.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002We prospectively collected blood sera of 85 patients with histologically proven tumour and 100 healthy blood donors. Ten microlitres of the sera was used for the DR\u201070 immunoassay. Nineteen patients had a hepatocellular and 10 cholangiocellular carcinoma, 13 cancer of the pancreas, 30 colorectal cancer, 10 stomach cancer and three cancer of the oesophagus.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Receiver\u2013operator curve analysis revealed &lt;0.7\u2003<jats:italic>\u03bc<\/jats:italic>g\/mL as the best cut\u2010off value to distinguish between patients with cancer and healthy controls. Using this cut\u2010off value, the DR\u201070 immunoassay showed a good clinical performance with a sensitivity of 91% and a specificity of 93%. Patients with advanced tumour spread showed significantly higher DR\u201070 values than those with early\u2010stage tumours (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0003).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002The DR\u201070 immunoassay reliably differs between cancer patients and healthy controls. Therefore, it promises to become a useful test for the detection of cancer in clinical practice.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02212.x","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T09:26:00Z","timestamp":1099387560000},"page":"983-987","source":"Crossref","is-referenced-by-count":25,"title":["The new DR\u201070 immunoassay detects cancer of the gastrointestinal tract: a validation study"],"prefix":"10.1111","volume":"20","author":[{"given":"A.","family":"Kerber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zgouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Caspary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Braden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,21]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/35025220"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.600"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600069"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3302"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.138.5.1056"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91968-2"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/01971529808005472"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02081408"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615611"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005950050144"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20336"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02212.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02212.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02212.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:43:59Z","timestamp":1697229839000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02212.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,21]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02212.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02212.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,21]]}}}